Altimmune, Inc. (ALT) Tops Q4 EPS by 7c
Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.